JP2010535473A5 - - Google Patents

Info

Publication number

JP2010535473A5

JP2010535473A5 JP2010519269A JP2010519269A JP2010535473A5 JP 2010535473 A5 JP2010535473 A5 JP 2010535473A5 JP 2010519269 A JP2010519269 A JP 2010519269A JP 2010519269 A JP2010519269 A JP 2010519269A JP 2010535473 A5 JP2010535473 A5 JP 2010535473A5

Authority

JP

Japan

Prior art keywords

cancer

ucr

subject

composition

related disease

Prior art date

2008-08-04

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Pending

Links

• Espacenet
• Global Dossier
• Discuss

• 206010028980 Neoplasm Diseases 0.000 claims 130
• 201000011510 cancer Diseases 0.000 claims 120
• 238000000034 method Methods 0.000 claims 90
• 108090000623 proteins and genes Proteins 0.000 claims 60
• 238000012360 testing method Methods 0.000 claims 41
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 40
• 201000010099 disease Diseases 0.000 claims 39
• 239000000203 mixture Substances 0.000 claims 32
• 208000008839 Kidney Neoplasms Diseases 0.000 claims 30
• 206010038389 Renal cancer Diseases 0.000 claims 30
• 201000010982 kidney cancer Diseases 0.000 claims 30
• 239000000523 sample Substances 0.000 claims 27
• 206010058467 Lung neoplasm malignant Diseases 0.000 claims 20
• 206010025323 Lymphomas Diseases 0.000 claims 20
• 208000005718 Stomach Neoplasms Diseases 0.000 claims 20
• 210000004027 cell Anatomy 0.000 claims 20
• 206010017758 gastric cancer Diseases 0.000 claims 20
• 201000005202 lung cancer Diseases 0.000 claims 20
• 208000020816 lung neoplasm Diseases 0.000 claims 20
• 201000011549 stomach cancer Diseases 0.000 claims 20
• 239000003153 chemical reaction reagent Substances 0.000 claims 18
• 230000002759 chromosomal effect Effects 0.000 claims 17
• 208000032852 chronic lymphocytic leukemia Diseases 0.000 claims 15
• 208000010839 B-cell chronic lymphocytic leukemia Diseases 0.000 claims 14
• 208000032839 leukemia Diseases 0.000 claims 14
• 208000031422 Lymphocytic Chronic B-Cell Leukemia Diseases 0.000 claims 13
• 210000000349 chromosome Anatomy 0.000 claims 13
• 239000008194 pharmaceutical composition Substances 0.000 claims 13
• 206010009944 Colon cancer Diseases 0.000 claims 11
• 208000024893 Acute lymphoblastic leukemia Diseases 0.000 claims 10
• 208000014697 Acute lymphocytic leukaemia Diseases 0.000 claims 10
• 208000031261 Acute myeloid leukaemia Diseases 0.000 claims 10
• 206010004593 Bile duct cancer Diseases 0.000 claims 10
• 206010005003 Bladder cancer Diseases 0.000 claims 10
• 208000003174 Brain Neoplasms Diseases 0.000 claims 10
• 206010006187 Breast cancer Diseases 0.000 claims 10
• 208000026310 Breast neoplasm Diseases 0.000 claims 10
• 201000009030 Carcinoma Diseases 0.000 claims 10
• 206010008342 Cervix carcinoma Diseases 0.000 claims 10
• 208000001333 Colorectal Neoplasms Diseases 0.000 claims 10
• 208000000461 Esophageal Neoplasms Diseases 0.000 claims 10
• 208000006168 Ewing Sarcoma Diseases 0.000 claims 10
• 208000021309 Germ cell tumor Diseases 0.000 claims 10
• 201000010915 Glioblastoma multiforme Diseases 0.000 claims 10
• 208000000172 Medulloblastoma Diseases 0.000 claims 10
• 201000003793 Myelodysplastic syndrome Diseases 0.000 claims 10
• 208000033776 Myeloid Acute Leukemia Diseases 0.000 claims 10
• 208000001894 Nasopharyngeal Neoplasms Diseases 0.000 claims 10
• 206010061306 Nasopharyngeal cancer Diseases 0.000 claims 10
• 208000034176 Neoplasms, Germ Cell and Embryonal Diseases 0.000 claims 10
• 206010029260 Neuroblastoma Diseases 0.000 claims 10
• 206010030155 Oesophageal carcinoma Diseases 0.000 claims 10
• 206010033128 Ovarian cancer Diseases 0.000 claims 10
• 206010061535 Ovarian neoplasm Diseases 0.000 claims 10
• 208000008900 Pancreatic Ductal Carcinoma Diseases 0.000 claims 10
• 208000006664 Precursor Cell Lymphoblastic Leukemia-Lymphoma Diseases 0.000 claims 10
• 206010060862 Prostate cancer Diseases 0.000 claims 10
• 208000000236 Prostatic Neoplasms Diseases 0.000 claims 10
• 208000000453 Skin Neoplasms Diseases 0.000 claims 10
• 206010041067 Small cell lung cancer Diseases 0.000 claims 10
• 208000024770 Thyroid neoplasm Diseases 0.000 claims 10
• 208000007097 Urinary Bladder Neoplasms Diseases 0.000 claims 10
• 208000006105 Uterine Cervical Neoplasms Diseases 0.000 claims 10
• 208000002495 Uterine Neoplasms Diseases 0.000 claims 10
• 208000008383 Wilms tumor Diseases 0.000 claims 10
• 208000026900 bile duct neoplasm Diseases 0.000 claims 10
• 201000010881 cervical cancer Diseases 0.000 claims 10
• 239000003795 chemical substances by application Substances 0.000 claims 10
• 208000006990 cholangiocarcinoma Diseases 0.000 claims 10
• 201000004101 esophageal cancer Diseases 0.000 claims 10
• 208000005017 glioblastoma Diseases 0.000 claims 10
• 201000010536 head and neck cancer Diseases 0.000 claims 10
• 208000014829 head and neck neoplasm Diseases 0.000 claims 10
• 208000019691 hematopoietic and lymphoid cell neoplasm Diseases 0.000 claims 10
• 201000007270 liver cancer Diseases 0.000 claims 10
• 208000014018 liver neoplasm Diseases 0.000 claims 10
• 210000003794 male germ cell Anatomy 0.000 claims 10
• 208000006178 malignant mesothelioma Diseases 0.000 claims 10
• 201000001441 melanoma Diseases 0.000 claims 10
• 201000008026 nephroblastoma Diseases 0.000 claims 10
• 201000008968 osteosarcoma Diseases 0.000 claims 10
• 201000008129 pancreatic ductal adenocarcinoma Diseases 0.000 claims 10
• 201000009410 rhabdomyosarcoma Diseases 0.000 claims 10
• 201000000849 skin cancer Diseases 0.000 claims 10
• 208000000587 small cell lung carcinoma Diseases 0.000 claims 10
• 201000002510 thyroid cancer Diseases 0.000 claims 10
• 206010044412 transitional cell carcinoma Diseases 0.000 claims 10
• 201000005112 urinary bladder cancer Diseases 0.000 claims 10
• 206010046766 uterine cancer Diseases 0.000 claims 10
• 239000003550 marker Substances 0.000 claims 9
• 230000004044 response Effects 0.000 claims 9
• 238000012216 screening Methods 0.000 claims 8
• 238000002560 therapeutic procedure Methods 0.000 claims 8
• 150000001875 compounds Chemical class 0.000 claims 7
• 108091070501 miRNA Proteins 0.000 claims 7
• 230000001105 regulatory effect Effects 0.000 claims 7
• 238000010171 animal model Methods 0.000 claims 6
• 239000003814 drug Substances 0.000 claims 6
• 239000002773 nucleotide Substances 0.000 claims 6
• 125000003729 nucleotide group Chemical group 0.000 claims 6
• 108091033319 polynucleotide Proteins 0.000 claims 6
• 102000040430 polynucleotide Human genes 0.000 claims 6
• 239000002157 polynucleotide Substances 0.000 claims 6
• 241001465754 Metazoa Species 0.000 claims 5
• 239000002299 complementary DNA Substances 0.000 claims 5
• 239000013068 control sample Substances 0.000 claims 5
• 238000009396 hybridization Methods 0.000 claims 5
• 238000002493 microarray Methods 0.000 claims 5
• 206010067671 Disease complication Diseases 0.000 claims 4
• 108700005087 Homeobox Genes Proteins 0.000 claims 4
• 241000701806 Human papillomavirus Species 0.000 claims 4
• 102000008394 Immunoglobulin Fragments Human genes 0.000 claims 4
• 108010021625 Immunoglobulin Fragments Proteins 0.000 claims 4
• 239000003937 drug carrier Substances 0.000 claims 4
• 230000000694 effects Effects 0.000 claims 4
• 108091008053 gene clusters Proteins 0.000 claims 4
• 238000000338 in vitro Methods 0.000 claims 4
• 230000010354 integration Effects 0.000 claims 4
• 230000000670 limiting effect Effects 0.000 claims 4
• 229940046166 oligodeoxynucleotide Drugs 0.000 claims 4
• 238000004393 prognosis Methods 0.000 claims 4
• 229940124597 therapeutic agent Drugs 0.000 claims 4
• 230000000295 complement effect Effects 0.000 claims 3
• 230000002452 interceptive effect Effects 0.000 claims 3
• 239000002679 microRNA Substances 0.000 claims 3
• 210000001519 tissue Anatomy 0.000 claims 3
• YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims 2
• 108091032973 (ribonucleotides)n+m Proteins 0.000 claims 2
• 108091026890 Coding region Proteins 0.000 claims 2
• 238000000018 DNA microarray Methods 0.000 claims 2
• 108090000790 Enzymes Proteins 0.000 claims 2
• 102000004190 Enzymes Human genes 0.000 claims 2
• 108091033773 MiR-155 Proteins 0.000 claims 2
• 108091034117 Oligonucleotide Proteins 0.000 claims 2
• 208000008601 Polycythemia Diseases 0.000 claims 2
• 241000251539 Vertebrata <Metazoa> Species 0.000 claims 2
• JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 claims 2
• 239000012472 biological sample Substances 0.000 claims 2
• 210000001124 body fluid Anatomy 0.000 claims 2
• 239000010839 body fluid Substances 0.000 claims 2
• 230000008859 change Effects 0.000 claims 2
• 239000013522 chelant Substances 0.000 claims 2
• 235000013376 functional food Nutrition 0.000 claims 2
• 230000012010 growth Effects 0.000 claims 2
• 230000001632 homeopathic effect Effects 0.000 claims 2
• 230000002401 inhibitory effect Effects 0.000 claims 2
• 230000003993 interaction Effects 0.000 claims 2
• 238000004519 manufacturing process Methods 0.000 claims 2
• 230000037353 metabolic pathway Effects 0.000 claims 2
• 239000002184 metal Substances 0.000 claims 2
• 230000035772 mutation Effects 0.000 claims 2
• 230000007918 pathogenicity Effects 0.000 claims 2
• 230000001575 pathological effect Effects 0.000 claims 2
• 230000007170 pathology Effects 0.000 claims 2
• 230000002441 reversible effect Effects 0.000 claims 2
• 210000003765 sex chromosome Anatomy 0.000 claims 2
• 230000019491 signal transduction Effects 0.000 claims 2
• 238000010561 standard procedure Methods 0.000 claims 2
• 238000001356 surgical procedure Methods 0.000 claims 2
• 108091062140 Mir-223 Proteins 0.000 claims 1
• 241000699666 Mus <mouse, genus> Species 0.000 claims 1
• 241000283973 Oryctolagus cuniculus Species 0.000 claims 1
• 241000288906 Primates Species 0.000 claims 1
• 241000700159 Rattus Species 0.000 claims 1
• 208000009956 adenocarcinoma Diseases 0.000 claims 1
• 230000003321 amplification Effects 0.000 claims 1
• 229960002685 biotin Drugs 0.000 claims 1
• 235000020958 biotin Nutrition 0.000 claims 1
• 239000011616 biotin Substances 0.000 claims 1
• 230000010261 cell growth Effects 0.000 claims 1
• 208000029742 colonic neoplasm Diseases 0.000 claims 1
• 238000012217 deletion Methods 0.000 claims 1
• 230000037430 deletion Effects 0.000 claims 1
• 238000001514 detection method Methods 0.000 claims 1
• 208000035475 disorder Diseases 0.000 claims 1
• 239000012634 fragment Substances 0.000 claims 1
• 230000000977 initiatory effect Effects 0.000 claims 1
• 238000002955 isolation Methods 0.000 claims 1
• 230000003211 malignant effect Effects 0.000 claims 1
• 108091032320 miR-146 stem-loop Proteins 0.000 claims 1
• 108091024530 miR-146a stem-loop Proteins 0.000 claims 1
• 108091092825 miR-24 stem-loop Proteins 0.000 claims 1
• 108091032978 miR-24-3 stem-loop Proteins 0.000 claims 1
• 108091064025 miR-24-4 stem-loop Proteins 0.000 claims 1
• 108091007432 miR-29b Proteins 0.000 claims 1
• 238000003199 nucleic acid amplification method Methods 0.000 claims 1
• 108020004707 nucleic acids Proteins 0.000 claims 1
• 102000039446 nucleic acids Human genes 0.000 claims 1
• 150000007523 nucleic acids Chemical class 0.000 claims 1
• 238000010837 poor prognosis Methods 0.000 claims 1
• 102000004169 proteins and genes Human genes 0.000 claims 1
• 230000011664 signaling Effects 0.000 claims 1
• 230000000392 somatic effect Effects 0.000 claims 1
• 239000000126 substance Substances 0.000 claims 1
• 230000004083 survival effect Effects 0.000 claims 1